These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1812721)

  • 1. Exploiting the molecular template of angiotensinogen in the discovery and design of peptidyl, pseudopeptidyl and peptidimimetic inhibitors of human renin: a structure-activity perspective.
    Sawyer TK; Hester JB; Schostarez HJ; Thaisrivongs S; Bundy GL; Liu L; Bradford VS; De Vaux AE; Staples DJ; Maggiora LL
    Adv Exp Med Biol; 1991; 306():307-23. PubMed ID: 1812721
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
    Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational aspects of angiotensinogen analogues with renin inhibitory activity.
    Liepina I; Nikiforovich GV; Paiva AC
    Biochem Biophys Res Commun; 1984 Jul; 122(2):700-5. PubMed ID: 6380499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide analogues of angiotensinogen. Effect of peptide chain length on renin inhibition.
    Plattner JJ; Greer J; Fung AK; Stein H; Kleinert HD; Sham HL; Smital JR; Perun TJ
    Biochem Biophys Res Commun; 1986 Sep; 139(3):982-90. PubMed ID: 3533075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformationally constrained renin inhibitory peptides: cyclic (3-1)-1-(carboxymethyl)-L-prolyl-L-phenylalanyl-L-histidinamide as a conformational restriction at the P2-P4 tripeptide portion of the angiotensinogen template.
    Thaisrivongs S; Blinn JR; Pals DT; Turner SR
    J Med Chem; 1991 Apr; 34(4):1276-82. PubMed ID: 2016704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
    Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
    Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents.
    Cooper JB; Foundling SI; Hemmings A; Watson FE; Sibanda BL; Blundell TL; Jones DM; Hallett A; Atrash B; Szelke M
    Biochem Soc Trans; 1987 Aug; 15(4):751-4. PubMed ID: 3119394
    [No Abstract]   [Full Text] [Related]  

  • 10. Cloning and characterization of marmoset renin: comparison with human renin.
    Valdenaire O; Breu V; Giller T; Bur D; Fischli W
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):893-7. PubMed ID: 10598135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin.
    Rahuel J; Rasetti V; Maibaum J; Rüeger H; Göschke R; Cohen NC; Stutz S; Cumin F; Fuhrer W; Wood JM; Grütter MG
    Chem Biol; 2000 Jul; 7(7):493-504. PubMed ID: 10903938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors. Dipeptide analogues of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond.
    Bolis G; Fung AK; Greer J; Kleinert HD; Marcotte PA; Perun TJ; Plattner JJ; Stein HH
    J Med Chem; 1987 Oct; 30(10):1729-37. PubMed ID: 3309313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New inhibitors of human renin that contain novel Leu-Val replacements.
    Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
    J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
    Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
    Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of inhibitors of human renin with high oral bioavailability.
    Hoover DJ; Lefker BA; Rosati RL; Wester RT; Kleinman EF; Bindra JS; Holt WF; Murphy WR; Mangiapane ML; Hockel GM
    Adv Exp Med Biol; 1995; 362():167-80. PubMed ID: 8540316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray-crystallographic studies of complexes of pepstatin A and a statine-containing human renin inhibitor with endothiapepsin.
    Bailey D; Cooper JB; Veerapandian B; Blundell TL; Atrash B; Jones DM; Szelke M
    Biochem J; 1993 Jan; 289 ( Pt 2)(Pt 2):363-71. PubMed ID: 8424781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin inhibitor SC-51106 complexed with human renin: discovery of a new binding site adjacent to P3.
    Hanson GJ; Clare M; Summers NL; Lim LW; Neidhart DJ; Shieh HS; Stevens AM
    Bioorg Med Chem; 1994 Sep; 2(9):909-18. PubMed ID: 7712126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent new inhibitors of human renin.
    Szelke M; Leckie B; Hallett A; Jones DM; Sueiras J; Atrash B; Lever AF
    Nature; 1982 Oct; 299(5883):555-7. PubMed ID: 6750410
    [No Abstract]   [Full Text] [Related]  

  • 19. Substrate specificity of human renin: the effect of substitutions at the amino terminus and P3 position of the substrate.
    Green DW; Rivetna MN
    Adv Exp Med Biol; 1991; 306():383-6. PubMed ID: 1812732
    [No Abstract]   [Full Text] [Related]  

  • 20. Ser84 of human renin contributes to the biphasic pH dependence of the renin-angiotensinogen reaction.
    Iwata H; Nakagawa T; Nishiuchi K; Hiratsuka T; Satou R; Yoshioka Y; Fukui Y; Suzuki F; Nakamura Y
    Biosci Biotechnol Biochem; 2007 May; 71(5):1279-85. PubMed ID: 17485830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.